| Market revenue in 2025 | USD 11,391.7 million |
| Market revenue in 2033 | USD 19,706.3 million |
| Growth rate | 7.1% (CAGR from 2026 to 2033) |
| Largest segment | Immunoassay |
| Fastest growing segment | Molecular Diagnostics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunoassay, Molecular Diagnostics |
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Diasorin SpA | View profile | 3,233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | www.diasoringroup.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | www.roche.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to STD Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Immunoassay was the largest segment with a revenue share of 47.88% in 2025.
Horizon Databook has segmented the Global std diagnostics market based on immunoassay, molecular diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of global-level data and insights on the Global STD Diagnostics Market Outlook, including forecasts for subscribers. This global databook contains high-level insights into Global STD Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.